Page last updated: 2024-10-15

a3080

Description

thiofentanil oxalate: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID122706842
MeSH IDM0415410

Synonyms (10)

Synonym
thiofentanil oxalate
A3080 ,
A-3080 ,
unii-5z3jx123qj
4-piperidinecarboxylic acid, 4-((2-methoxyacetyl)phenylamino)-1-(2-(2-thienyl)ethyl)-, methyl ester, ethanedioate
101365-73-5
dea no.9729
5z3jx123qj ,
thiafentanil oxalate
AKOS040749643

Dosage Studied

ExcerptReference
" Anesthesia was rapidly and completely reversed by intravenous injections of naltrexone at 30 times the THAI dosage (0."( Anesthesia of boma-captured Lichtenstein's hartebeest (Sigmoceros lichtensteinii) with a combination of thiafentanil, medetomidine, and ketamine.
Bush, M; Citino, SB; Grobler, D; Lance, W, 2002
)
" The optimum dosage for nyala was a combination of A3080 (40-50 microg/kg), MED (60-80 microg/kg) plus 200 mg of KET/animal."( Anaesthesia of nyala (Tragelaphus angasi) with a combination of thiafentanil (A3080), medetomidine and ketamine.
Bush, M; Cooper, DV; Grobler, D; Jessup, D; Lance, W, 2005
)
" On the basis of rapid, smooth, and successful inductions and recoveries, the described dosage of thiafentanil and medetomidine, with administration of midazolam prior to recovery, is recommended for immobilization of adult emus."( Use of thiafentanil-medetomidine for the induction of anesthesia in emus (Dromaius novaehollandiae) within a wild animal park.
Cushing, A; McClean, M, 2010
)
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (26)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (3.85)18.2507
2000's6 (23.08)29.6817
2010's14 (53.85)24.3611
2020's5 (19.23)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials5 (19.23%)5.53%
Reviews0 (0.00%)6.00%
Case Studies2 (7.69%)4.05%
Observational0 (0.00%)0.25%
Other19 (73.08%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]